A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

Published:2005-06 Issue:16_suppl Volume:23 Page:LBA7024-LBA7024
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Jassem J.¹,Zatloukal P.¹,Ramlau R.¹,Schwarzenberger P. O.¹,Orlov S.¹,Rodrigues-Pereira J.¹,Temperley G. J.¹,Mabry M.¹,Negro-Vilar A.¹,Dziewanowska Z.¹

Affiliation:

1. Medcl Univ of Gdansk, Gdansk, Poland; Budinova 2, Prague, Czech Republic; Great Poland Lung Diseases Ctr, Poznan, Poland; Louisiana State Univ, New Orleans, LA; Pavlov State Medcl Univ, St. Petersburg, Russian Federation; R. Martinico, Sao Paulo, Brazil; Hosp Municipal de Oncologia Madame Curie, Buenos Aires, Argentina; Ligand Pharmaceuticals, San Diego, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2005.23.16_suppl.lba7024

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation by bexarotene of mRNA expression of genes in mouse lung tumors;Molecular Carcinogenesis;2007-09-11

2. Lung Cancer;Journal of Thoracic Oncology;2007-05

3. The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer;Cancer Letters;2007-04

4. Novel Targeted Therapies for Non–Small Cell Lung Cancer;Thoracic Surgery Clinics;2006-11

5. Non‐Small‐Cell Lung Cancer;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15